Combination of Fludarabine and Imatinib Induces Apoptosis Synergistically Through Loss of Mitochondrial Membrane Potential and Increases in Caspase-3 Enzyme Activity in Human K562 Chronic Myleloid Leukemia Cells

Loading...

Date

Journal Title

Journal ISSN

Volume Title

Open Access Color

BRONZE

Green Open Access

Yes

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Average

relationships.isProjectOf

relationships.isJournalIssueOf

Abstract

In this study, we aimed to show the synergistic apoptotic effects of imatinib/fludarabine combination in human K562 chronic myleloid leukemia (CML) cells. There was a significant increase in cytotoxicity of combination of imatinib and fludarabine as compared to any agent alone. On the other hand, combination of both agents induced apoptosis significantly as confirmed by increases in caspase-3 enzyme activity and decreases in mitochondrial membrane potential. As a summary, the results of this study strongly suggest that combination of imatinib and fludarabine induced cell death synergistically comparing to only imatinib or fludarabine in human K562 CML cells. Copyright © 2010 Informa Healthcare USA, Inc.

Description

Keywords

Apoptosis, BCR/ABL, Chronic myeloid leukemia, Fludarabine, Imatinib, Apoptosis, Piperazines, Fludarabine, Inhibitory Concentration 50, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Combined Chemotherapy Protocols, Humans, BCR/ABL, Cell Proliferation, Membrane Potential, Mitochondrial, Cell Death, Dose-Response Relationship, Drug, Caspase 3, Chronic myeloid leukemia, Drug Synergism, Mitochondria, Pyrimidines, Imatinib, Benzamides, Imatinib Mesylate, K562 Cells, Vidarabine

Fields of Science

0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine

Citation

Baran, Y., Öztekin, C., and Başsoy, E. Y. (2010). Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells. Cancer Investigation, 28(6), 623-628. doi:10.3109/07357901003631056

WoS Q

Scopus Q

OpenCitations Logo
OpenCitations Citation Count
7

Volume

28

Issue

6

Start Page

623

End Page

628
PlumX Metrics
Citations

CrossRef : 4

Scopus : 6

PubMed : 1

Captures

Mendeley Readers : 11

SCOPUS™ Citations

6

checked on Apr 29, 2026

Web of Science™ Citations

6

checked on Apr 29, 2026

Page Views

840

checked on Apr 29, 2026

Downloads

514

checked on Apr 29, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
0.36262943

Sustainable Development Goals

GOOD HEALTH AND WELL-BEING3
GOOD HEALTH AND WELL-BEING